BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2025 7:47:21 AM | Browse: 165 | Download: 377
 |
Received |
|
2025-01-11 05:45 |
 |
Peer-Review Started |
|
2025-01-11 05:45 |
 |
First Decision by Editorial Office Director |
|
2025-03-11 21:25 |
 |
Return for Revision |
|
2025-03-11 21:25 |
 |
Revised |
|
2025-04-27 04:29 |
 |
Publication Fee Transferred |
|
2025-04-29 02:10 |
 |
Second Decision by Editor |
|
2025-07-02 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-07-02 06:33 |
 |
Articles in Press |
|
2025-07-02 06:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-07-22 03:37 |
 |
Publish the Manuscript Online |
|
2025-07-24 07:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lei Ma, Meng-Han Zhang, Yi-Fan Xu, Yan-Xu Hao, Xuan-Xuan Niu, Yan Li and Hui-Chun Xing |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key R&D Program of China |
2022YFC2304500 and 2021YFC2301801 |
| Beijing Municipal of Science and Technology Major Project |
Z221100007422002 |
| Capital Funds for Health Improvement and Research |
CFH-2024-1-2181 |
| Beijing Igandan Foundation |
iGandanF-1082023-GSH011 |
|
| Corresponding Author |
Hui-Chun Xing, Chief Physician, MD, PhD, Professor, Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. hchxing@sohu.com |
| Key Words |
Chronic liver disease; Fecal microbiota transplantation; Intestinal microbiota; Liver-gut axis; Clinical efficacy |
| Core Tip |
Fecal microbiota transplantation shows significant potential in treating chronic liver diseases by improving liver inflammation, biomarkers, lipid metabolism, and cognitive function. It works through the liver-gut axis, restoring intestinal microbiota balance. Despite promising results, challenges remain in donor selection, standard treatment protocols, and long-term safety. Ongoing clinical trials and further research are needed to refine protocols and establish standardized approaches for optimal efficacy and safety in managing chronic liver diseases. |
| Publish Date |
2025-07-24 07:47 |
| Citation |
Ma L, Zhang MH, Xu YF, Hao YX, Niu XX, Li Y, Xing HC. Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease. World J Gastroenterol 2025; 31(28): 105089 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i28/105089.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i28.105089 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.